AGP Executive Report
Last update: 7 hours agoPreventive Care: Bangladesh plans to recruit 100,000 healthcare workers, 80% women, to promote prevention nationwide. Stroke Treatment: The FDA approved asundexian, a once-daily add-on to antiplatelet therapy that reduced ischemic strokes in a pivotal trial without a significant rise in major bleeding. Measles: Pennsylvania has recorded seven deaths and 1,542 cases in its outbreak; the U.S. has more than 5,400 cases, and reports say it has lost measles-elimination status after sustained spread. Cancer Research: An NIH study found higher blood levels of two PFAS chemicals were associated with up to 93% higher rates of aggressive, estrogen-receptor-negative breast cancer; it found no clear link to breast cancer overall. Diabetes: World Diabetes Day spotlights early detection, as many people have no symptoms for years. Experts also warn that South Asians can face elevated risk at lower BMI, underscoring the need for broader screening and care. Drug Quality: Indonesia’s BPOM and Europe’s EDQM are partnering to strengthen medicine standards and testing, while Lilly has begun work on a $3.5 billion Pennsylvania manufacturing site.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
